drugset / Trial / NCT00829634
Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation
Completed
12 enrolled
California Pacific Medical Center Research Institute
National Institutes of Health (NIH) · collabSan Francisco General Hospital · collabUniversity of California, San Francisco · collab
NaSingle-groupOpen-labelBasic science
Summary
The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEVMETAMFETAMINE | Small molecule | 5 mg | Oral |
| Subject | d-methamphetamine | Unknown | 15 mg | — |
| Subject | d-methamphetamine | Unknown | 30 mg | — |
| Subject | d-methamphetamine | Unknown | 45 mg | — |